Endpoints at #ASCO25

11:00 AM - 11:30 AM ET

Expert’s panel: Cancer research under federal uncertainty

How are regulatory and economic uncertainties affecting the outlook for cancer research? Join an Endpoints News reporter and a panel of leading cancer researchers, industry insiders and experts to look ahead at oncology pipelines and cover how data readouts from the conference will affect the next year in cancer treatment.

11:35 AM - 12:05 PM ET

Filling funding gaps: In conversation with Karen Knudsen

Karen Knudsen took over as the new CEO of the Parker Institute for Cancer Immunotherapy in March. Hear how she plans to position the institute in a time when the traditional cancer research paradigm is on unstable footing.

12:10 PM - 12:40 PM ET

The future is now: Digital transformation unleashes precision medicine in community oncology

This panel will provide actionable and practical steps for community oncology practices to seamlessly integrate precision medicine into their daily workflows. It will focus on leveraging technology to improve efficiency, reduce error, and enhance patient care in a respectful, compassionate and empowering manner. Learn how to embrace digital transformation in a way that puts the patient at the center of care.

Jason Hammonds

COO, Oncology & Specialty

McKesson

Terri Conneran

Founder

KRAS Kickers

Eric Lander

Medical Oncologist & Hematologist; Site Research Leader

Minnesota Oncology, a practice in The US Oncology Network

Andrew McKenzie

VP, Personalized Medicine | Scientific Director

Sarah Cannon Research Institute (SCRI) | Genospace

Surani Fernando

Moderator

Healthcare Journalist, Writer & Podcast Producer

Raising Biotech Podcast

12:45 PM - 1:15 PM ET

Precision medicine: Exploring the power of mutational testing to deliver personalized treatment plans

Precision medicine is redefining the healthcare landscape by creating personalized treatment plans that can dramatically improve patient outcomes. This approach is shaping patient-centered healthcare and pioneering a new era of medical innovation and collaboration. Hear from leading experts as they explore the transformative impact of precision medicine, providing insights into integrating precision medicine into clinical practice and how mutational testing serves as a cornerstone for developing targeted therapies.